127 related articles for article (PubMed ID: 15555143)
1. Schizophrenia.
Nadeem Z; McIntosh A; Lawrie S
Clin Evid; 2003 Dec; (10):1208-37. PubMed ID: 15555143
[No Abstract] [Full Text] [Related]
2. Schizophrenia.
McIntosh A; Lawrie S
Clin Evid; 2004 Dec; (12):1502-33. PubMed ID: 15865730
[No Abstract] [Full Text] [Related]
3. Schizophrenia.
Lawrie S; McIntosh A; Nadeem Z
Clin Evid; 2005 Dec; (14):1306-30. PubMed ID: 16620456
[No Abstract] [Full Text] [Related]
4. [Atypical antipsychotics].
Naber D
Nervenarzt; 2000 May; 71(5):327-8. PubMed ID: 10846707
[No Abstract] [Full Text] [Related]
5. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Kapur S; Remington G
Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
[TBL] [Abstract][Full Text] [Related]
6. [Current pharmacotherapy of schizophrenia].
Bitter I
Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
[No Abstract] [Full Text] [Related]
8. [Zotepin--its value and potentials for further development].
Nervenarzt; 1994 Jul; 65(7 Suppl):1-8. PubMed ID: 9218060
[No Abstract] [Full Text] [Related]
9. [Late schizophrenia].
Morishita S
Ryoikibetsu Shokogun Shirizu; 2003; (38):80-3. PubMed ID: 12876935
[No Abstract] [Full Text] [Related]
10. Treatment of clozapine-associated tardive dyskinesia.
Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
[No Abstract] [Full Text] [Related]
11. Acute respiratory distress due to antipsychotic drugs.
Yagmur F; Ulusoy HB; Buyukoglan H; Kaya MG
Pharmacopsychiatry; 2010 May; 43(3):118-9. PubMed ID: 20446229
[No Abstract] [Full Text] [Related]
12. Amisulpride augmentation of clozapine in refractory schizophrenia.
Chiu HW; Ku YC; Li TC; Huang HT
J Neuropsychiatry Clin Neurosci; 2011; 23(3):E15. PubMed ID: 21948906
[No Abstract] [Full Text] [Related]
13. Amisulpride: a review of its efficacy in schizophrenia.
Möller HJ
Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
[TBL] [Abstract][Full Text] [Related]
14. [The features of atypical neuroleptic amisulpride action].
Grigor'eva EA; Ritskov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):59-64. PubMed ID: 15285638
[No Abstract] [Full Text] [Related]
15. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
Kämpf P; Agelink MW; Naber D
Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
[No Abstract] [Full Text] [Related]
16. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Svestka J; Synek O; Tomanová J; Rodáková I; Cejpková A
Neuro Endocrinol Lett; 2007 Dec; 28(6):881-8. PubMed ID: 18063941
[TBL] [Abstract][Full Text] [Related]
17. Tardive dystonia induced by switch of atypical antipsychotics.
Chen CC; Chen YY; Hung GC
Pharmacopsychiatry; 2010 Jul; 43(5):200-1. PubMed ID: 20486043
[No Abstract] [Full Text] [Related]
18. Targeting cognition in schizophrenia research: from etiology to treatment.
Goldberg TE; Gomar JJ
Am J Psychiatry; 2009 Jun; 166(6):631-4. PubMed ID: 19487396
[No Abstract] [Full Text] [Related]
19. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
Kahn RS; Fleischhacker WW; Boter H; Davidson M; Vergouwe Y; Keet IP; Gheorghe MD; Rybakowski JK; Galderisi S; Libiger J; Hummer M; Dollfus S; López-Ibor JJ; Hranov LG; Gaebel W; Peuskens J; Lindefors N; Riecher-Rössler A; Grobbee DE;
Lancet; 2008 Mar; 371(9618):1085-97. PubMed ID: 18374841
[TBL] [Abstract][Full Text] [Related]
20. Switching to amisulpride due to hepatic complications.
Yagdiran O; Haasen C; Nika E; Krausz M; Naber D
Eur Psychiatry; 2002 May; 17(3):170-1. PubMed ID: 12052579
[No Abstract] [Full Text] [Related]
[Next] [New Search]